» Articles » PMID: 34136384

Value of Pyruvate Carboxylase in Thyroid Fine-Needle Aspiration Wash-Out Fluid for Predicting Papillary Thyroid Cancer Lymph Node Metastasis

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 Jun 17
PMID 34136384
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The incidence of papillary thyroid carcinoma (PTC) is increasing. Lymph node metastatic status of PTC is a major factor for decision marking of surgery and surgical extend, however, no reliable tool exists for prediction of PTC nodal metastasis, for example, ultrasound cannot qualitatively diagnose and effectively detect central lymph node metastasis (CLNM). Therefore, the development of a new diagnostic biomarker is crucial for CLNM. Metabolic dysregulation is an important factor associated with malignancy and metastasis of tumors. Pyruvate carboxylase (PC) is a major anaplerotic enzyme that catalyzes the carboxylation of pyruvate to form oxaloacetate, which has been suggested to be involved in the tumorigenesis of several cancers, including PTC. This study aimed to explore the role of expression in thyroid fine-needle aspiration (FNA) wash-out fluid for predicting CLNM in PTC, and to explore how PC is involved in PTC development. The expression levels of in PTC tissues and normal thyroid tissues were first compared based on bioinformatics analysis of public databases, including the Gene Expression Profiling (GEPIA), Oncomine and Gene Expression Omnibus (GEO) databases. Then, the mRNA and protein expression levels were measured by RT-PCR and Immunohistochemistry (IHC) in surgical tissues from a total of 42 patients with surgically confirmed PTC, and compared in patients with and without CLNM. Further, to assess expression in diagnostic biopsies, a total of 71 thyroid nodule patients with ultrasound-guided FNA wash-out fluid samples and cytological diagnosis were prospectively enrolled in the study. Then, we analyzed the mechanism of PC-mediated PTC progression . This study showed that PC expression was higher in PTC tissues and thyroid FNA wash-out fluid samples from patients with CLNM than those from patients without CLNM, and that PC-induced PTC metastasis may occur through the TGF-β/Smad-regulated epithelial-mesenchymal transition (EMT) pathway.

Citing Articles

tRF-1:30-Gly-CCC-3 inhibits thyroid cancer via binding to PC and modulating metabolic reprogramming.

Fu B, Lou Y, Lu X, Wu Z, Ni J, Jin C Life Sci Alliance. 2023; 7(3).

PMID: 38081642 PMC: 10713435. DOI: 10.26508/lsa.202302285.


Pyruvate carboxylase promotes malignant transformation of papillary thyroid carcinoma and reduces iodine uptake.

Liu Y, Liu C, Pan Y, Zhou J, Ju H, Zhang Y Cell Death Discov. 2022; 8(1):423.

PMID: 36266265 PMC: 9585021. DOI: 10.1038/s41420-022-01214-y.


The Epithelial-Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression.

Fedele M, Sgarra R, Battista S, Cerchia L, Manfioletti G Int J Mol Sci. 2022; 23(2).

PMID: 35054987 PMC: 8776206. DOI: 10.3390/ijms23020800.

References
1.
Alexander E, Kennedy G, Baloch Z, Cibas E, Chudova D, Diggans J . Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med. 2012; 367(8):705-15. DOI: 10.1056/NEJMoa1203208. View

2.
Ren H, Shen Y, Hu D, He W, Zhou J, Cao Y . Co-existence of and promoter mutations in papillary thyroid carcinoma is associated with tumor aggressiveness, but not with lymph node metastasis. Cancer Manag Res. 2018; 10:1005-1013. PMC: 5937490. DOI: 10.2147/CMAR.S159583. View

3.
Cappola A, Mandel S . Molecular testing in thyroid cancer: BRAF mutation status and mortality. JAMA. 2013; 309(14):1529-30. DOI: 10.1001/jama.2013.3620. View

4.
Baek S, Jung K, Kang S, Kwon S, Woo J, Cho S . Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma. Thyroid. 2009; 20(2):147-52. DOI: 10.1089/thy.2008.0243. View

5.
Hu H, Chen D, Wang Y, Feng Y, Cao G, Vaziri N . New insights into TGF-β/Smad signaling in tissue fibrosis. Chem Biol Interact. 2018; 292:76-83. DOI: 10.1016/j.cbi.2018.07.008. View